LumiraDx Ltd (LMDXF)
0.025
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
LumiraDx Cash from Financing (TTM): 58.14M for June 30, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
June 30, 2023 | 58.14M |
March 31, 2023 | 109.29M |
December 31, 2022 | 165.29M |
September 30, 2022 | 203.13M |
Date | Value |
---|---|
June 30, 2022 | 101.00M |
March 31, 2022 | 51.74M |
December 31, 2021 | 219.02M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
51.74M
Minimum
Mar 2022
219.02M
Maximum
Dec 2021
129.66M
Average
109.29M
Median
Mar 2023
Cash from Financing (TTM) Benchmarks
RadNet Inc | 195.64M |
DermTech Inc | 6.079M |
Centogene NV | -- |
iSpecimen Inc | 0.0709M |
23andMe Holding Co | 4.19M |